ADCT · ADC Therapeutics SA
$1.01
-0.04 (-3.81%)
At close · Aug 14
Market Cap
$128.94M
Shares
127.67M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2024-06-18 | Robert Azelby | Director | 6,995 | 2024-06-17 | Morgan Stanley |
| 2024-06-18 | Jean Bizzari | Director | 6,995 | 2024-06-17 | Morgan Stanley |
| 2024-06-18 | Ron Squarer | Director | 6,995 | 2024-06-17 | Morgan Stanley |
| 2024-06-18 | Victor Sandor | Director | 6,995 | 2024-06-17 | Morgan Stanley |
| 2024-05-07 | Ameet Mallik | Officer and Director | 29,731 | 2024-05-07 | Morgan Stanley |
Showing 1–5 of 5 filings
Key facts
CIK
1771910
CUSIP
H0036K147
13F (30d)
113 filings
110 filers
Visit website
Investor relations